LAYERED EDIBLE PRODUCT FOR MULTI-STAGE DOSING OF MULTI-FUNCTION ACTIVE PHARMACEUTICAL INGREDIENTS
A layered edible product includes a core and at least one active layer that is supported by the core. The at least one active layer can include a respective API. The edible product is configured to be placed against a mucosal surface of the oral cavity, which causes the respective API of the at least one active layer to enter the bloodstream through the mucosal surface. The core can be ingested gastrointestinally or can be dissolvable against the mucosal surface or both. The core can include a core API, or optionally the core can be API-free.
1 . A layered edible product comprising:
a core comprising a core active pharmaceutical ingredient (API); and
an inner active layer disposed over the core, the inner active layer comprising an inner API, wherein the inner active layer is dissolvable against a sublingual mucosa and a buccal mucosa.
2 . The layered edible product of claim 1 , wherein the inner API is different than the core API.
3 . The layered edible product of claim 1 , wherein the core API and the inner API comprise the same constituent components but in different proportions.
4 . The layered edible product of claim 1 , wherein the core is devoid of cannabis.
5 . The layered edible product of claim 1 , wherein the core and the inner active layer defines an edible body, and the layered edible product further comprises a wrapper that covers at least an outermost surface of the edible body.
6 . The layered edible product of claim 5 , wherein the wrapper is dissolvable by saliva against the sublingual mucosa and the buccal mucosa.
7 . The layered edible product of claim 5 , wherein the wrapper is configured for removal from the edible body prior to placement of the edible body into the mouth.
8 . The layered edible product of claim 5 , wherein the wrapper is inert.
9 . The layered edible product of claim 1 , wherein the inner active layer defines an outermost active layer of the layered edible product.
10 . The layered edible product of claim 9 , wherein the inner active layer also defines an innermost active layer such that no active layer is disposed between the inner active layer and the core.
11 . The layered edible product of claim 9 , wherein the inner active layer is the only active layer of the layered edible product.
12 . The layered edible product of claim 1 , wherein the core and the inner active layer have different flavor profiles.
13 . The layered edible product of claim 1 , wherein the inner API has a therapeutic effect configured to last for a shorter time duration than the core active pharmaceutical ingredient.
14 . The layered edible product of claim 13 , wherein the core API is configured to increase in the bloodstream after the inner API has begun decreasing in the bloodstream.
15 . The layered edible product of claim 2 , further comprising an outer active layer disposed over the inner active layer, such that the inner active layer is disposed between the core and the outer active layer, the inner active layer comprises the inner API, and the outer active layer comprises an outer API.
16 . The multilayer edible product of claim 15 , wherein the inner and outer active layers are each configured to dissolve against a sublingual mucosa and a buccal mucosa.
17 . The layered edible product of claim 16 , wherein the outer API and the inner API comprise the same constituent components but in different proportions.
18 . The layered edible product of claim 16 , wherein the inner API has different constituent components than the outer API.
19 . The layered edible product of claim 18 , further comprising an inert partition layer disposed between the inner and outer active layers.
20 . The layered edible product of claim 15 , further comprising an inert partition layer disposed between the core and the inner active layer.
21 . The layered edible product of claim 15 , wherein the outer active layer substantially entirely encapsulates the inner active layer.
22 . The layered edible product of claim 15 , wherein the inner and outer API are configured to last for a shorter time duration in the bloodstream than the core active pharmaceutical ingredient.
23 . The layered edible product of claim 15 , wherein the core API is configured to increase in the bloodstream after the inner and outer APIs have begun decreasing in the bloodstream.
24 . The layered edible product of claim 1 , wherein the core comprises one of a gummy candy, a hard candy, a chocolate candy, a dried fruit, and a nut.
25 . The layered edible product of claim 1 , wherein the inner active layer substantially entirely encapsulates the core.
26 . The layered edible product of claim 1 , wherein an outer core surface of the core faces the inner active layer, and a core inner surface of the core opposite the outer core surface of the core faces away from the inner active layer.